Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2002

A radical approach to cancer.

Undurti Das

Med Sci Monit 2002; 8(4): RA79-92 :: ID: 420857

Abstract

Reactive oxygen species are known to be potentially dangerous, but arealso needed for signal-transduction pathways. Tumor cells have relatively low amounts of superoxide dismutase(SOD), which quenches superoxide anion (O2(-*)), and as a result of a higher level of aerobic metabolism,higher concentrations of O2(-*) , compared to normal cells. But this may not be true of all tumor cells.Some tumor cells have relatively higher amounts of vitamin E, a potent anti-oxidant, and a higher levelof anaerobic metabolism, resulting in a balance that is tilted more towards higher anti-oxidant capacity.In both instances of higher aerobic and anaerobic metabolism methods designed to augment free radicalgeneration in tumor cells can cause their death. It is suggested that free radicals and lipid peroxidessuppress the expression of Bcl-2, activate caspases and shorten telomere, and thus inducing apoptosisof tumor cells. Ionizing radiation, anthracyclines, bleomycin and cytokines produce free radicals andthus are useful as anti-cancer agents. But they also produce many side-effects. 2-methoxyoestradiol andpolyunsaturated fatty acids (PUFAs) inhibit SODs and cause an increase of O2(-*) in tumor cells leadingto their death. In addition, PUFAs (especially gamma-linolenic acid), 2-methoxyoestradiol and thalidomidemay possess anti-angiogenic activity. This suggests that free radicals can suppress angiogenesis. Limitedclinical studies done with gamma-linolenic acid showed that it can regress human brain gliomas withoutany significant side-effects. Thus, PUFAs, thalidomide and 2-methoxyoestradiol or their derivatives mayoffer a new radical approach to the treatment of cancer.

Keywords: Anaerobiosis, Angiogenesis Inhibitors, Cell Division, Fatty Acids, Unsaturated, Free Radicals, Lipid Peroxidation, Neoplasm Proteins, Neoplasms, Neovascularization, Pathologic, Superoxides, Telomere, thalidomide, Vitamin E

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750